Skip to main content
Clinical Trials/NCT04001426
NCT04001426
Completed
N/A

Pilot Phase for an Acute Evaluation of a Non-Implantable Electrical Continence Device

FemPulse Corporation1 site in 1 country2 target enrollmentApril 4, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Urinary Bladder, Overactive
Sponsor
FemPulse Corporation
Enrollment
2
Locations
1
Primary Endpoint
Evoked Potential response
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this feasibility clinical investigation is to investigate a new medical device treatment for Overactive Bladder (OAB) in women.

Detailed Description

The FemPulse System is a vaginal ring intended to provide mild electrical stimulation to nerves that regulate bladder function. It is believed that stimulation of these nerves may help relieve the symptoms of OAB.

Registry
clinicaltrials.gov
Start Date
April 4, 2019
End Date
December 31, 2019
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Normal healthy women ≥ 21 years old
  • Using contraception if of reproductive age

Exclusion Criteria

  • Pregnant, recently pregnant or actively trying to conceive
  • Prior hysterectomy
  • Current or recent urinary tract or vaginal infection

Outcomes

Primary Outcomes

Evoked Potential response

Time Frame: Up to 6 hours

Surface electrodes will be used to detect whether evoked potentials are generated during device activation

Autonomic nervous system response

Time Frame: Up to 6 hours

The Quantitative Sudomotor Axon Reflex Test (QSART) will be used to detect changes in autonomic nervous system activity during device activation

Study Sites (1)

Loading locations...

Similar Trials